No evidence that HPV vaccination leads to sexual risk compensation

References

• Marlow LAV, Waller J, Wardle J. Parental attitudes to pre-pubertal HPV vaccination. Vaccine 2007; 25:1945-52; PMID:17284337; http://dx.doi.org/10.1016/j.vaccine.2007.01.059
   PubMed Web of Science ®Google Scholar
• Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12-9; PMID:10451482; http://dx.doi.org/10.1002/(SICI)1096-9896(199909)189:1%3c12:AID-PATH431%3e3.0.CO;2-F
   PubMed Web of Science ®Google Scholar
• Villa L, Perez G, Kjaer S, Lehtinen M, Paavonen J, Munoz N, et al. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. Lancet 2007; 369:1861-8; PMID:17544766; http://dx.doi.org/10.1016/S0140-6736(07)60852-6
   PubMed Web of Science ®Google Scholar
• Paavonen J, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009; 374:301-14; PMID:19586656; http://dx.doi.org/10.1016/S0140-6736(09)61248-4
   PubMed Web of Science ®Google Scholar
• Hansen BT, Campbell S, Burger E, Nygard M. Correlates of HPV vaccine uptake in school-based routine vaccination of preadolescent girls in Norway: A register-based study of 90,000 girls and their parents. Prev Med 2015; 77:4-10; PMID:25944266; http://dx.doi.org/10.1016/j.ypmed.2015.04.024
   PubMed Web of Science ®Google Scholar
• Hilton S, Hunt K, Langan M, Bedford H, Petticrew M. Newsprint media representations of the introduction of the HPV vaccination programme for cervical cancer prevention in the UK (2005–2008). Soc Sci Med 2010; 70:942-50; PMID:20064682; http://dx.doi.org/10.1016/j.socscimed.2009.11.027
   PubMed Web of Science ®Google Scholar
• Assum T, Bjornskau T, Fosser S, Sagberg F. Risk compensation–the case of road lighting. Accident Anal Prev 1999; 31:545-53; http://dx.doi.org/10.1016/S0001-4575(99)00011-1
   PubMed Web of Science ®Google Scholar
• Phillips RO, Fyhri A, Sagberg F. Risk compensation and bicycle helmets. Risk Anal 2011; 31:1187-95; PMID:21418079; http://dx.doi.org/10.1111/j.1539-6924.2011.01589.x
   PubMed Web of Science ®Google Scholar
• Sagberg F, Fosser S, Saetermo IA. An investigation of behavioural adaptation to airbags and antilock brakes among taxi drivers. Accident Anal Prev 1997; 29:293-302; http://dx.doi.org/10.1016/S0001-4575(96)00083-8
   PubMed Web of Science ®Google Scholar
• Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, Williams CF, Campbell RT, Ndinya-Achola JO. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007; 369:643-56; PMID:17321310; http://dx.doi.org/10.1016/S0140-6736(07)60312-2
   PubMed Web of Science ®Google Scholar
• Sobngwi-Tambekou J, Taljaard D, Nieuwoudt M, Lissouba P, Puren A, Auvert B. Male circumcision and Neisseria gonorrhoeae, Chlamydia trachomatis and Trichomonas vaginalis: observations after a randomised controlled trial for HIV prevention. Sex Transm Infect 2009; 85:116-20; PMID:19074928; http://dx.doi.org/10.1136/sti.2008.032334
   PubMed Web of Science ®Google Scholar
• Kibira SP, Nansubuga E, Tumwesigye NM, Atuyambe LM, Makumbi F. Differences in risky sexual behaviors and HIV prevalence of circumcised and uncircumcised men in Uganda: evidence from a 2011 cross-sectional national survey. Reprod Health 2014; 11:25; PMID:24656204; http://dx.doi.org/10.1186/1742-4755-11-25
   PubMed Web of Science ®Google Scholar
• Westercamp N, Agot K, Jaoko W, Bailey RC. Risk compensation following male circumcision: results from a two-year prospective cohort study of recently circumcised and uncircumcised men in Nyanza Province, Kenya. AIDS Behav 2014; 18:1764-75; PMID:25047688; http://dx.doi.org/10.1007/s10461-014-0846-4
   PubMed Web of Science ®Google Scholar
• Pinkerton SD. Sexual risk compensation and HIV/STD transmission: empirical evidence and theoretical considerations. Risk Anal 2001; 21:727-36; PMID:11726023; http://dx.doi.org/10.1111/0272-4332.214146
   PubMed Web of Science ®Google Scholar
• Secura GM, Adams T, Buckel CM, Zhao Q, Peipert JF. Change in sexual behavior with provision of no-cost contraception. Obstet Gynecol 2014; 123:771-6; PMID:24785603; http://dx.doi.org/10.1097/AOG.0000000000000184
   PubMed Web of Science ®Google Scholar
• Crepaz N, Hart TA, Marks G. Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review. JAMA 2004; 292:224-36; PMID:15249572; http://dx.doi.org/10.1001/jama.292.2.224
   PubMed Web of Science ®Google Scholar
• Stolte IG, de Wit JB, van Eeden A, Coutinho RA, Dukers NH. Perceived viral load, but not actual HIV-1-RNA load, is associated with sexual risk behaviour among HIV-infected homosexual men. Aids 2004; 18:1943-9; PMID:15353980; http://dx.doi.org/10.1097/00002030-200409240-00010
   PubMed Web of Science ®Google Scholar
• Vanable PA, Ostrow DG, McKirnan DJ, Taywaditep KJ, Hope BA. Impact of combination therapies on HIV risk perceptions and sexual risk among HIV-positive and HIV-negative gay and bisexual men. Health Psychol 2000; 19:134-45; PMID:10762097; http://dx.doi.org/10.1037/0278-6133.19.2.134
   PubMed Web of Science ®Google Scholar
• Blumenthal J, Haubrich RH. Will risk compensation accompany pre-exposure prophylaxis for HIV? Virtual Mentor 2014; 16:909-15; PMID:25397651; http://dx.doi.org/10.1001/virtualmentor.2014.16.11.stas1-1411
   PubMedGoogle Scholar
• Kasting ML, Shapiro GK, Rosberger Z, Kahn JA, Zimet GD. Tempest in a teapot: A systematic review of HPV vaccination and risk compensation research. Hum Vaccin Immunother 2016; Feb 10:1–16; PMID:26864126.
   PubMed Web of Science ®Google Scholar
• Ogilvie G, Anderson M, Marra F, McNeil S, Pielak K, Dawar M, McIvor M, Ehlen T, Dobson S, Money D, et al. A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: Parental factors associated with HPV vaccine receipt. Plos Medicine 2010; 7:e1000270; PMID:20454567; http://dx.doi.org/10.1371/journal.pmed.1000270
   PubMed Web of Science ®Google Scholar
• Elfstrom KM, Dillner J, Arnheim-Dahlstrom L. Organization and quality of HPV vaccination programs in Europe. Vaccine 2015; 33:1673-81; PMID:25720792; http://dx.doi.org/10.1016/j.vaccine.2015.02.028
   PubMed Web of Science ®Google Scholar
• Baldur-Felskov B, Dehlendorff C, Munk C, Kjaer SK. Early impact of human papillomavirus vaccination on cervical neoplasia–nationwide follow-up of young Danish women. J Natl Cancer Inst 2014; 106:djt460; PMID:24552678; http://dx.doi.org/10.1093/jnci/djt460
   PubMed Web of Science ®Google Scholar
• Arnheim-Dahlstrom L, Pasternak B, Svanstrom H, Sparen P, Hviid A. Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study. Br Med J 2013; 347:f5906; http://dx.doi.org/10.1136/bmj.f5906
   PubMed Web of Science ®Google Scholar